Completed

Predictive Modeling for Treatment of Upper Airway Obstruction in Young Children

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Congenital Abnormalities+9

+ Jaw Abnormalities

+ Jaw Diseases

Until 17 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: April 2011
See protocol details

Summary

Principal SponsorUniversity of North Carolina, Chapel Hill
Last updated: April 20, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2011

Actual date on which the first participant was enrolled.

The investigators hypothesize that a functional computational model that simulates the mechanical and aerodynamic behavior of the upper airway in children with Pierre Robin Sequence (PRS) and laryngeal lesions (e.g. subglottic stenosis or SGS) can be used as an effective diagnostic and treatment planning tool.

NCT01690078
Principal SponsorUniversity of North Carolina, Chapel Hill
Last updated: April 20, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

39 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Until 17 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Congenital AbnormalitiesJaw AbnormalitiesJaw DiseasesStomatognathic DiseasesMusculoskeletal AbnormalitiesMusculoskeletal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesStomatognathic System AbnormalitiesCraniofacial AbnormalitiesMaxillofacial AbnormalitiesMicrognathismPierre Robin Syndrome

Criteria

Inclusion Criteria: Micrognathia, Suspected or Diagnosis of PRS, defined (Gorlin) as: micrognathia (mandibular hypoplasia), cleft palate and airway obstruction, and/or Diagnosis of SGS defined (Bluestone) as: subglottic airway diameter of 4 mm or less in a term neonate; subglottic airway diameter of 3.5 mm or less in a premature neonate; inability to pass an endotracheal tube of expected size for age Informed consent by parent or legal guardian Age < 18 years at enrollment Scheduled for clinically indicated endoscopic upper airway evaluation Ability to comply with study visits and study procedures as judged by the site investigator Inclusion criterion also included for Specific Aim 2 (Longitudinal): Subjects must be scheduled for an operative procedure to correct or bypass upper airway obstruction (i.e. mandibular distraction, endoscopic airway surgery, laryngotracheoplasty, cricotracheal resection, or tracheostomy) OR recently (within past 4 weeks) diagnosed as having an anomaly not currently requiring surgical management. Exclusion Criteria: Acute, intercurrent respiratory infection, defined as an increase from baseline in cough, wheezing, or respiratory rate with onset in the preceding week. Physical findings at screening that would compromise the safety of the participant or the quality of the study (i.e. fever, increased respiratory rate above baseline, significant acute emesis, or alteration in baseline neurologic status). For research CT scans any sedation risk, such as Bronchopulmonary Dysplasia (BPD) with upper airway obstruction, residual oxygen requirement, and an unsecured airway. Control data will be collected from clinically indicated neck or maxillofacial CT imaging data that include the entire airway with no noted airway obstructions or airway abnormalities.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

3 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

North Carolina Children's Hospital

Chapel Hill, United StatesOpen North Carolina Children's Hospital in Google Maps
CompletedOne Study Center